MyChesCo on MSN
FDA moves to cut costs for biosimilar drug development
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced new draft guidance aimed at reducing the cost and ...
Compounding pharmacies are illegally selling GLP-1 drugs, and the FDA is determined to shut that pathway down.
Gottlieb is a senior fellow at the American Enterprise Institute and served as commissioner of the Food and Drug Administration from 2017 to 2019. President Trump often touted during his first term ...
The Food and Drug Administration on Tuesday published a list of brand name drugs without generic competition and implemented a policy to accelerate generic drug approvals. The actions represent the ...
The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs designed to fill unmet medical needs and treat serious conditions. The FDA Fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results